User: Guest

IMMUNO-ONCOLOGY

Global Market Trajectory & Analytics

MCP12538

VALIDATED EXECUTIVE ENGAGEMENTS

POOL + OUTREACH

7883
Number of executives repeatedly engaged by snail & email outreach

INTERACTIONS

1104
Interactions with Platform & by Email

PARTICIPANTS

236
Unique # Participated

VALIDATIONS

106
Responses Validated*
* Login to view program details and full enterprise executive list.

DATE

JUL 2020

TABLES

80

PAGES

157

EDITION

9

PRICE

USD $4950


Amid the COVID-19 crisis, the global market for Immuno-Oncology estimated at US$63.9 Billion in the year 2020, is projected to reach a revised size of US$163.1 Billion by 2027, growing at a CAGR of 14.3% over the analysis period 2020-2027. Immune Checkpoint Inhibitors, one of the segments analyzed in the report, is projected to record a 14.2% CAGR and reach US$143.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Immune System Modulators segment is readjusted to a revised 15% CAGR for the next 7-year period.
The Immuno-Oncology market in the U.S. is estimated at US$18.9 Billion in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$28.4 Billion by the year 2027 trailing a CAGR of 13.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 12.7% and 12.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 10.5% CAGR.
In the global Cancer Vaccines segment, USA, Canada, Japan, China and Europe will drive the 15.4% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$1.5 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$19.5 Billion by the year 2027.We bring years of research experience to this 9th edition of our report. The 157-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.
AbbVie, Inc.; Aduro BioTech, Inc.; Amgen, Inc.; AstraZeneca PLC; Bavarian Nordic A/S; Bristol-Myers Squibb Company; Celgene Corporation; Celldex Therapeutics, Inc.; Eli Lilly and Company; EMD Serono, Inc.; F. Hoffmann-La Roche AG; Galena Biopharma, Inc.; Gilead Sciences, Inc.; ImmunoCellular Therapeutics Ltd.; Incyte Corporation; Johnson & Johnson; Merck & Co., Inc.; Novartis International AG; Pfizer, Inc.; Prometheus Laboratories, Inc.; Sanofi SA
» Cancer Type (Melanoma, Lung Cancer, Blood Cancer, Renal Cell Carcinoma, Bladder Cancer, Other Cancer Types) » Therapy Type (Immune Checkpoint Inhibitors, Immune System Modulators, Cancer Vaccines, Oncolytic Virus, Other Therapy Types)
» World » United States » Canada » Japan » China » Europe » France » Germany » Italy » United Kingdom » and Rest of Europe » Asia-Pacific » Rest of World

INSIDER ACCESS PRIVILEGES

Users of our portal have insider access to our data stacks based on project relevance and engagement status. Tiered access is offered to data stacks, managed based on user status - Opt-in, Active Panelist, Inactive Panelist, Active Client or Inactive Client.

ACTIVE CLIENT

INACTIVE CLIENT

ACTIVE PANELIST

INACTIVE PANELIST

OPT-INS

FEATURED COMPANIES

Registration is required to access our data stacks.

WORLD BRANDS

Registration is required to access our data stacks.

EXECUTIVES ENGAGED

Registration is required to access our data stacks.

KEY DIFFERENTIATORS

We are firmly committed to build upon perspectives from global executive insights. These engagements enrich our projects. Our primary research programs are fully validated and accessible by clients. (Its a common industry-wide* practice that no validated primary research is done! For the most part, remote resident analysts curate and write reports drawing on search engine research and data modeling.

* A review of 262 off-the-shelf market report publishers worldwide.

WHAT SETS US APART
Client companies can access multiple features on our MarketGlass™ platform.

Clients have full-stack insider access to our ongoing primary research program. We have a very successful incentive driven primary research program that benefits participating executives regardless of their purchase decision. Our platform presents a unique opportunity to collaborate with peers and review competitors’ inputs and response clusters.

Detailed engagement stats are presented for every company and executive contacted. This is made available for our client reviews. (no other publisher offers this!)

A full-stack access to clients of all primary and secondary source content. This can often run into thousands of pages.

Where relevent and possible we present competitive brands.

Peer-to-peer online interactive collaborations. Allows for team curated bespoke analytics.

Customers can update and build bespoke versions of our analytics. Bespoke updates are fulfilled within a two-day turnaround.

Discretely bounce off queries to participant pool of executives. Our embedded AI selectively pings participants geographically and by domain acumen.

We pride in our commitment to provide support to our clients. We go beyond the scope of the study to get you timely answers.

Unlike the industry’s published PDF’s that are frozen in time from date of release, our research programs are ongoing and dynamic. Our reports are updated whenever there’s a major event impacting the marketplace. Your license offers seamless updates for one year.

All updates are offered for one year from date of your purchase without charge. Clients can opt for annual auto renewal and stay current without interruption.

  
05
1. MARKET OVERVIEW
Global Competitor Market Shares
Immuno-Oncology Competitor Market Share Scenario Worldwide (in %): 2019 & 2025
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
Immuno-Oncology Global Market Estimates and Forecasts in US$ Million by Region/Country: 2020-2027
Immuno-Oncology Market Share Shift across Key Geographies Worldwide: 2020 VS 2027
Immune Checkpoint Inhibitors (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027
Immune Checkpoint Inhibitors (Therapy Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
Immune System Modulators (Therapy Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Immune System Modulators (Therapy Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
Cancer Vaccines (Therapy Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Cancer Vaccines (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Oncolytic Virus (Therapy Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Oncolytic Virus (Therapy Type) Market Share Breakdown by Region/Country: 2020 VS 2027
Other Therapy Types (Therapy Type) World Market by Region/Country in US$ Million: 2020 to 2027
Other Therapy Types (Therapy Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Melanoma (Cancer Type) World Market Estimates and Forecasts in US$ Million by Region/Country: 2020 to 2027
Melanoma (Cancer Type) Market Percentage Share Distribution by Region/Country: 2020 VS 2027
Lung Cancer (Cancer Type) Market Opportunity Analysis Worldwide in US$ Million by Region/Country: 2020 to 2027
Lung Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Blood Cancer (Cancer Type) World Market by Region/Country in US$ Million: 2020 to 2027
Blood Cancer (Cancer Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2020 VS 2027
Renal Cell Carcinoma (Cancer Type) Potential Growth Markets Worldwide in US$ Million: 2020 to 2027
Renal Cell Carcinoma (Cancer Type) Market Sales Breakdown by Region/Country in Percentage: 2020 VS 2027
Bladder Cancer (Cancer Type) Geographic Market Spread Worldwide in US$ Million: 2020 to 2027
Bladder Cancer (Cancer Type) Market Share Distribution in Percentage by Region/Country: 2020 VS 2027
Other Cancer Types (Cancer Type) World Market Estimates and Forecasts by Region/Country in US$ Million: 2020 to 2027
Other Cancer Types (Cancer Type) Market Share Breakdown by Region/Country: 2020 VS 2027
GEOGRAPHIC MARKET ANALYSIS
UNITED STATES
Market Facts & Figures
US Immuno-Oncology Market Share (in %) by Company: 2019 & 2025
United States Immuno-Oncology Market Estimates and Projections in US$ Million by Therapy Type: 2020 to 2027
United States Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
United States Immuno-Oncology Market Estimates and Projections in US$ Million by Cancer Type: 2020 to 2027
United States Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
CANADA
Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027
Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027
Canadian Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027
Immuno-Oncology Market in Canada: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027
JAPAN
Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027
Japanese Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Japanese Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027
Japanese Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
CHINA
Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027
Chinese Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027
Chinese Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027
Chinese Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027
EUROPE
Market Facts & Figures
European Immuno-Oncology Market: Competitor Market Share Scenario (in %) for 2019 & 2025
European Immuno-Oncology Market Demand Scenario in US$ Million by Region/Country: 2018-2025
European Immuno-Oncology Market Share Shift by Region/Country: 2020 VS 2027
European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027
European Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
European Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027
European Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
FRANCE
Immuno-Oncology Market in France by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027
French Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in France by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027
French Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
GERMANY
Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Therapy Type for the Period 2020-2027
German Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in Germany: Recent Past, Current and Future Analysis in US$ Million by Cancer Type for the Period 2020-2027
German Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
ITALY
Italian Immuno-Oncology Market Growth Prospects in US$ Million by Therapy Type for the Period 2020-2027
Italian Immuno-Oncology Market by Therapy Type: Percentage Breakdown of Sales for 2020 and 2027
Italian Immuno-Oncology Market Growth Prospects in US$ Million by Cancer Type for the Period 2020-2027
Italian Immuno-Oncology Market by Cancer Type: Percentage Breakdown of Sales for 2020 and 2027
UNITED KINGDOM
United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Therapy Type for the Period 2020-2027
United Kingdom Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
United Kingdom Market for Immuno-Oncology: Annual Sales Estimates and Projections in US$ Million by Cancer Type for the Period 2020-2027
United Kingdom Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
REST OF EUROPE
Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020-2027
Rest of Europe Immuno-Oncology Market Share Breakdown by Therapy Type: 2020 VS 2027
Rest of Europe Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020-2027
Rest of Europe Immuno-Oncology Market Share Breakdown by Cancer Type: 2020 VS 2027
ASIA-PACIFIC
Immuno-Oncology Market in Asia-Pacific by Therapy Type: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Immuno-Oncology Market Share Analysis by Therapy Type: 2020 VS 2027
Immuno-Oncology Market in Asia-Pacific by Cancer Type: Estimates and Projections in US$ Million for the Period 2020-2027
Asia-Pacific Immuno-Oncology Market Share Analysis by Cancer Type: 2020 VS 2027
REST OF WORLD
Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Therapy Type: 2020 to 2027
Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Therapy Type for 2020 and 2027
Rest of World Immuno-Oncology Market Estimates and Forecasts in US$ Million by Cancer Type: 2020 to 2027
Immuno-Oncology Market in Rest of World: Percentage Share Breakdown of Sales by Cancer Type for 2020 and 2027
Total Companies Profiled : 47

Click here to request a full table of contents and more details on this project.

INSIDER ACCESS TO

 METHODOLOGY  QUESTIONNAIRE  INFLUENCER NETWORK

Registration is required to access our data stacks.

RESEARCH PANEL

Panelists are carefully chosen based on their domain expertise and market influence.

Participation in our expert panels is only by invitation. Our project focused panels are constituted of senior executives in business strategy, marketing, sales, and product management at competitive companies worldwide. We also welcome individuals from leading management consulting, venture capital, private equity, investment management and related firms with domain expertise and are actively monitoring specific companies or industries. Our panelists bring unique market perspectives and unbiased intelligence to our ongoing research programs.

Our panelists give 30-minutes a month or a one-time 30-minute participation based on their time and willingness.

  • Complimentary previews of full stack research data for participated
  • Insider access to research programs including engagements and stats from other panelists
  • Unlimited research credits of $1000 per participated project
  • Competitive Intelligence Alerts including engagements from other panelists and validated participants worldwide relevant to your company
  • Interact with other panelists via our MarketGlassTM Data Exchange Platform*
  • BlogX - Panelists can use our blogging platform publish their viewpoints on news relevant to their domain expertise. Platform enables panelists to share their viewpoints on current news and events related to their areas domain expertise with timely and insightful blogs*

* Complete details will be shared with panelists upon formal acceptance.

 GLOBAL EXPERT PANEL

YOUR PRIVACY MATTERS!

Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.

What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: Privacy@StrategyR.com